Blocking endotoxin may reverse cognitive decline of aging
Another study implicating endotoxin (LPS) and its associated receptor (TLR4) in a phenotype of aging considered “normal” by mainstream medicine, though it almost universally progresses into dementia territory with advancing age, to the point where 90%+ of people over 85 have at least moderate levels of dementia, even if not officially diagnosed with Alzheimer’s disease … Read more